These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down's syndrome with transient abnormal myelopoiesis. Arai H, Ishida A, Nakajima W, Nishinomiya F, Yamazoe A, Takada G. Hum Pathol; 1999 Apr; 30(4):474-6. PubMed ID: 10208471 [Abstract] [Full Text] [Related]
7. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome. Wilkie AO, Kitchen C, Oakhill A, Howell RT, Berry PJ. J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817 [Abstract] [Full Text] [Related]
8. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Zipursky A, Thorner P, De Harven E, Christensen H, Doyle J. Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285 [Abstract] [Full Text] [Related]
10. Megakaryoblastic leukemia and Down's syndrome--a review. Zipursky A, Peeters M, Poon A. Prog Clin Biol Res; 1987 Mar; 246():33-56. PubMed ID: 2958881 [No Abstract] [Full Text] [Related]
11. [Diffuse liver fibrosis associated with transient myeloproliferative disorder in Down's syndrome]. Villamor Zambrano E, Alonso Ortiz T, Arizcun Pineda J, Moro Serrano M. An Esp Pediatr; 1997 Jul; 47(1):69-70. PubMed ID: 9382333 [No Abstract] [Full Text] [Related]
12. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome. Ito E, Kasai M, Hayashi Y, Toki T, Arai K, Yokoyama S, Kato K, Tachibana N, Yamamoto M, Yokoyama M. Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001 [Abstract] [Full Text] [Related]
15. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome. Ma SK, Lee AC, Wan TS, Lam CK, Chan LC. Leukemia; 1999 Mar; 13(3):491-2. PubMed ID: 10086746 [No Abstract] [Full Text] [Related]
16. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome. Sunami S, Fuse A, Simizu B, Eguchi M, Hayashi Y, Sugita K, Nakazawa S, Okimoto Y, Sato T, Nakajima H. Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817 [Abstract] [Full Text] [Related]
17. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome. Klusmann JH, Reinhardt D, Hasle H, Kaspers GJ, Creutzig U, Hahlen K, van den Heuvel-Eibrink MM, Zwaan CM. Leukemia; 2007 Jul; 21(7):1584-7. PubMed ID: 17443226 [No Abstract] [Full Text] [Related]
18. Isolated pericardial effusion and transient abnormal myelopoiesis in a fetus with Down's syndrome. Hirashima C, Eguchi Y, Kohmura Y, Minakami H, Sato I. J Obstet Gynaecol Res; 2000 Aug; 26(4):303-6. PubMed ID: 11049242 [Abstract] [Full Text] [Related]
20. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome. Roy A, Roberts I, Vyas P. Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527 [Abstract] [Full Text] [Related] Page: [Next] [New Search]